A study of two drugs Amritvalli-Ghrit and Aragvadhadi-ghrit after Therapeutic Emesis in Ek-Kustha (Psoriasis)
Phase 2
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2023/05/052220
- Lead Sponsor
- ATIONAL INSTITUTE OF AYURVEDA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients willing for trial.
2.Clinically diagnosed and confirmed cases of Psoriasis
Exclusion Criteria
1.Patients with age below 18 and above 60 yrs.
2.Pregnant women and lactating mothers.
3.Patients suffering from serious systemic disorders like Diabetes Mellitus, Cardiac and
Renal Disorders, Malignant disease, Major liver disorders etc.
4.Patients having complication of Psoriasis like Psoriatic Arthropathy, erythrodermic psoriasis etc.
5.Patients Contraindicated for vamana karma as per classical Ä?yurveda texts.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To see the changes in the PASI Score and the other Subjective parameters grading score.Timepoint: 2 weeks, 4 weeks and 8 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method Changes in the objective parameters of disease. <br/ ><br>Timepoint: 2 weeks, 4 weeks and 8 weeks